The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021/05/03 by David N. Louis, Arie Perry, Pieter Wesseling +10 · 73 citations
Medicine · #Brain Metastases and Treatment #Glioma Diagnosis and Treatment #Neuroblastoma Research and Treatments
paper · pdf · doi:10.1093/neuonc/noab106
openalex publication_date 2021/05/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Abstract
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
Citations
Cited by
- Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms
- Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO <i>resect</i> group
- Prognostic stratification of newly diagnosed <i>IDH-</i> mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET: A retrospective, bicentric cohort study
- The BraTS-Africa Dataset: Expanding the Brain Tumor Segmentation Data to Capture African Populations
- Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma
- Glioblastoma-Secreted C1QL1 Orchestrates Tumor Microtube Expansion and Neural Synaptic Pruning to Drive Malignant Synapse Formation and Recurrence
- Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
- Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4
- Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
- Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
- Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy
- Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
- Arterial spin labelling: predictive role in surgical bleeding of paediatric optic pathway gliomas
- Self-Supervised Text-Vision Alignment for Automated Brain MRI Abnormality Detection: A Multicenter Study (ALIGN Study)
- Cancer-myeloid cell invasive program in pediatric-type diffuse high-grade glioma
- Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas
- ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis
- Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
- Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement
- Cross-Platform DNA Methylation Classifier for the Eight Molecular Subtypes of Group 3 & 4 Medulloblastoma
- Clonal evolution and therapy resistance in the era of precision cancer medicine: evolutionary trajectories in pediatric cancer
- Leveraging the Mononuclear Phagocyte System for Advancing Glioma Theranostics: Current Insights and Future Directions
- First experimental measurements of biophotons from Astrocytes and Glioblastoma cell cultures
- Hierarchical Generalized Category Discovery for Brain Tumor Classification in Digital Pathology
- eccDNABase: A Comprehensive and High-Quality Database for Extrachromosomal Circular DNA
- Multifunctional metal oxide nanoparticles for diverse therapeutic approaches in glioblastoma
- The prognostic impact of <i>CDKN2A/B</i> hemizygous deletions in meningioma
- Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
- Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma models
- Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
- Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
- <scp>cIMPACT</scp>‐<scp>NOW</scp> update 10: Recommendations for defining new types for central nervous system tumor classification
- A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry
- Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors
- The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
- The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know
- Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular Subgroups
- STRATUM project: AI-based point of care computing for neurosurgical 3D decision support tools
- Modelling brain tumours with organoids: towards precision medicine in neuro-oncology
- cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas
- Glutathione metabolism-related gene signature predicts prognosis and treatment response in low-grade glioma
- EANS-EANO guidelines on the extent of resection in gliomas
- Network-Based Prediction of Oligodendroglioma Driver Gene Candidates within the Region of the 1p/19q Co-deletion Utilizing Single-Cell Transcriptomes
- Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study
- Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment
- Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients
- Survival Analysis of Patients Undergoing Intraoperative Contrast-enhanced Ultrasound in the Surgical Treatment of Malignant Glioma
- Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
- A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma
- Insights into the Structural Patterns in Human Glioblastoma Cell Line SF268 Activity and ADMET Prediction of Curcumin Derivatives
- The multilayered transcriptional architecture of glioblastoma ecosystems
- Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics
- Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication
- Predicting cognitive function 3 months after surgery in patients with a glioma
- Standardisation of the radiological definition of supramaximal resection in glioblastoma
- Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
- Therapy enhancing chromosome instability may be advantageous for <i>IDH1</i>R132H/WT gliomas
- A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging
- Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes
- Extracellular Matrix Structure and Interaction with Immune Cells in Adult Astrocytic Tumors
- PROFUSEme: PROstate Cancer Biochemical Recurrence Prediction via FUSEd Multi-modal Embeddings
- DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma
- Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkers
- Ganglioglioma revealed by spontaneous intracerebral hematoma: A cohort study
- Pediatric sellar teratoma – Case report and review of the literature
- Complexity-Informed Causal Modeling of Neurodevelopmental Trajectories in Pediatric High-Grade Gliomas: Divergences from Neural Stem Cell Signatures
- Performance of GPT-5 in Brain Tumor MRI Reasoning
- Automatic and standardized surgical reporting for central nervous system tumors
- FoundBioNet: A Foundation-Based Model for IDH Genotyping of Glioma from Multi-Parametric MRI
- IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma
- Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities
- Masked Omics Modeling for Multimodal Representation Learning across Histopathology and Molecular Profiles
- OpenSRH: optimizing brain tumor surgery using intraoperative stimulated Raman histology
Related